Silver Book Fact

The cost-effectiveness of detection and treatment of eye disease in diabetics is $3,190 per quality adjusted life year (QALY).

Javitt J, Aiello L. Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy. Annals of Internal Medicine. 1996; 124(1): 164-9. http://www.annals.org/cgi/content/abstract/124/1_Part_2/164

Reference

Title
Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy
Publication
Annals of Internal Medicine
Publication Date
1996
Authors
Javitt J, Aiello L
Volume & Issue
Volume 124, Issue 1
Pages
164-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The ACCORD Eye Study found that combination lipid therapy with a fibrate and statin (compared with statin treatment alone) reduced progression of diabetic retinopathy in type 2 diabetics by around…  
  • Omega-3 polyunsaturated fatty acids have been found to protect against the development and progression of deterioration of the retina (retinopathy).  
  • The ACCORD Eye Study found that intensive glycemia control–compared with standard blood sugar control–in high risk type 2 diabetics, decreased progression of diabetic retinopathy by around 1/3 over 4 years–from…  
  • Because the resource use and direct cost of glaucoma treatment and management increases as the disease severity worsens– from an average $623 per early-stage patient to $2,511 per late-stage patient–…  
  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.